hereby certify that the above report is complete and true in all respects. ลงช่ือ / Signature of reporter……………………………………….. ตําแหนง / Position …….….…….……….………………………….. บริษัท / Company …………….………….………………………….
○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ SEC Board Appointed under the Securities and Exchange Act (No. 4) B.E. 2551 (2008) Mr. Vijit Supinit Chairman of the Board He graduated with a BA in Economics (Honors) from University of Manchester, UK
of Modern Pharma Company Limited With regards to the meeting of the Board of Directors of Inter Pharma Public Company Limited, “the Company" No. 4/2020, dated 8th June 2020, resolutions are herebelow
entitled to inspect his account and name. Section 16. As regards the transfer of assets under an approved project, if the assets are secured by security other than rights of mortgage, rights of pledge or
the transferred assets. A debtor shall be entitled to inspect his account and name. Section 16. As regards the transfer of assets under an approved project, if the assets are secured by security other
, Australia; and (v) Ankleshwar, India. IVL would like to inform that all formalities with regards to the said Transaction has been completed on 3rd January 2020. This acquisition reinforces IVL’s Integrated
the business providers, including the information of the mutual funds, private funds, and provident funds, especially in regards of investment statuses, strategies of funds, and the concentration of
▲ 6 ▲ 9 ▲ 11 ▲ 2 ▲ 5 ▲ 8 Appointed under the Securities and Exchange Act (No. 4) B.E. 2551 (2008) SEC Board 7 1. Mr. Vijit Supinit Chairman He graduated with a B.A. in Economics (Honors) from University
to comply therewith in all respects. In this regard, I would be pleased to provide additional information upon the SEC Office’s request for the benefit of the application consideration and the
to comply therewith in all respects. In this regard, I would be pleased to provide additional information upon the SEC Office’s request for the benefit of the application consideration and the